Filing Details
- Accession Number:
- 0001140361-18-031775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-06 16:05:02
- Reporting Period:
- 2018-07-03
- Accepted Time:
- 2018-07-06 16:05:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447028 | Arbutus Biopharma Corp | ABUS | Pharmaceutical Preparations (2834) | 980597776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635324 | J. Michael Sofia | C/O Arbutus Biopharma Corp. Suite 100, 8900 Glenlyon Parkway Burnaby A1 V5J 5J8 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2018-07-03 | 10,000 | $8.00 | 1,543,403 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2018-07-05 | 10,000 | $8.40 | 1,533,403 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 171,412 | Indirect | Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
Billionaire Hedge Funds
